Interim report
Page 1
Stock code : 000963 The Third Quarterly Report 2021 of Huadong Medicine Co. , Ltd. Stock abbreviation : Huadong Medicine Announcement No .: 2021-076 Huadong Medicine Co. , Ltd. The Third Quarterly Report 2021 The Company and all members of the Board of Directors hereby guarantee that the information presented in this report is authentic , accurate and complete and free of any false records , misleading statements or material omissions . Important Declaration : 1.The Board of Directors , Board of Supervisors , directors , supervisors and senior management of Huadong Medicine Co. , Ltd. ( hereinafter referred to as the " Company " ) hereby guarantee that the information presented in this report is authentic , accurate and complete and free of any false records , misleading statements or material omissions , and shall undertake individual and joint legal liabilities . 2.The Company's legal representative and the officer in charge of accounting , and head of accounting department ( accounting supervisor ) hereby declare and guarantee that the financial statements in this quarter report are authentic , accurate and complete . 3.Has the third quarterly report been audited ? □ Yes √ No This report is prepared both in Chinese and English . Should there be any discrepancy between the Chinese and English versions , the Chinese version shall prevail . I. Key financial data ( I ) Key Accounting Data and Financial Indicators Whether the Company needs to perform retroactive adjustment or restatement of previous accounting data □ Yes No From the beginning of the year to the end of the reporting period 25,927,477,363.27 Change from the beginning of the year to the end of the reporting period over the same period last year 1.67 % The current reporting period Change of the current reporting period over the same period last year 8,748,039,460.66 -1.04 % shareholders of listed 595,038,254.49 -9.88 % 1,895,384,579.34 -20.74 % companies ( yuan ) Net profit attributable to 568,039,187.19 -9.00 % 1,762,020,074.37 | -13.24 % shareholders of listed Operating revenue ( yuan ) Net profit attributable to 1